AXA S.A. - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 1 filers reported holding CLOVIS ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
AXA S.A. ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q1 2022$83,612
-92.3%
41,200
-89.7%
0.00%
-100.0%
Q4 2021$1,088,000
-33.5%
401,300
+17.6%
0.00%
-40.0%
Q4 2020$1,637,000
-16.5%
341,100
+1.4%
0.01%
-28.6%
Q3 2020$1,961,000
-58.4%
336,351
-51.8%
0.01%
-22.2%
Q2 2020$4,710,000
+341.0%
697,800
+4344.6%
0.01%
+125.0%
Q4 2017$1,068,000
-63.4%
15,700
-55.6%
0.00%
-69.2%
Q3 2017$2,917,000
+72.8%
35,400
-26.6%
0.01%
+85.7%
Q4 2015$1,688,000
-32.8%
48,230
+76.5%
0.01%
-30.0%
Q3 2015$2,513,000
+50.0%
27,330
-8.7%
0.01%
+42.9%
Q4 2014$1,675,000
+30.6%
29,919
+5.8%
0.01%
+40.0%
Q3 2014$1,283,000
+8.8%
28,283
-0.6%
0.01%0.0%
Q2 2014$1,179,000
-42.5%
28,465
-3.9%
0.01%
-44.4%
Q1 2014$2,051,000
+21.2%
29,610
+5.5%
0.01%
+12.5%
Q4 2013$1,692,000
+4.4%
28,068
+5.2%
0.01%0.0%
Q3 2013$1,621,00026,6720.01%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 814,833$60,485,054,00053.20%
Palo Alto Investors LP 2,121,857$157,505,0007.79%
NEA Management Company, LLC 2,279,781$169,228,0007.65%
EcoR1 Capital, LLC 243,048$18,041,0006.01%
Redmile Group, LLC 900,879$66,872,0006.00%
Opaleye Management Inc. 140,000$10,392,0004.82%
PFM Health Sciences, LP 2,266,756$168,261,0004.64%
Partner Investment Management, L.P. 40,798$3,028,0004.56%
CLIFTON PARK CAPITAL MANAGEMENT, LLC 826,919$61,383,0003.74%
Opus Point Partners Management, LLC 55,988$4,156,0003.48%
View complete list of CLOVIS ONCOLOGY INC shareholders